Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 343,344 shares of the company's stock, valued at approximately $32,769,000. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.28% of Clorox as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in CLX. Haverford Trust Co boosted its stake in Clorox by 2.8% in the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company's stock worth $310,000 after purchasing an additional 84 shares during the period. Field & Main Bank raised its stake in shares of Clorox by 3.3% in the 4th quarter. Field & Main Bank now owns 3,100 shares of the company's stock valued at $313,000 after purchasing an additional 100 shares during the period. Golden State Wealth Management LLC lifted its holdings in shares of Clorox by 28.2% in the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company's stock valued at $46,000 after purchasing an additional 100 shares in the last quarter. Kestra Private Wealth Services LLC lifted its holdings in shares of Clorox by 1.8% in the first quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company's stock valued at $617,000 after purchasing an additional 104 shares in the last quarter. Finally, Johnson Financial Group Inc. boosted its position in shares of Clorox by 3.1% during the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company's stock worth $451,000 after buying an additional 109 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Clorox Stock Down 1.8%
NYSE:CLX opened at $106.00 on Friday. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $128.90. The firm has a market capitalization of $12.82 billion, a price-to-earnings ratio of 21.99, a price-to-earnings-growth ratio of 3.23 and a beta of 0.54. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The stock's 50 day moving average price is $98.77 and its two-hundred day moving average price is $103.11.
Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The company had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. The firm's revenue for the quarter was down 2.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Equities research analysts expect that The Clorox Company will post 5.8 earnings per share for the current fiscal year.
Clorox Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th will be given a $1.25 dividend. This is a boost from Clorox's previous quarterly dividend of $1.24. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.7%. Clorox's payout ratio is 103.73%.
Analyst Ratings Changes
A number of brokerages recently issued reports on CLX. Morgan Stanley dropped their target price on Clorox from $110.00 to $97.00 and set an "equal weight" rating on the stock in a research report on Friday, May 1st. BNP Paribas Exane decreased their price target on shares of Clorox from $97.00 to $95.00 and set a "neutral" rating for the company in a research note on Monday, July 20th. Wells Fargo & Company lifted their price objective on shares of Clorox from $95.00 to $102.00 and gave the company an "equal weight" rating in a report on Tuesday, August 4th. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $92.00 to $95.00 and gave the stock an "underweight" rating in a research report on Tuesday, August 4th. Finally, Citigroup raised their target price on shares of Clorox from $97.00 to $100.00 and gave the company a "neutral" rating in a research report on Tuesday, August 4th. Twelve investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Reduce" and an average target price of $102.40.
Get Our Latest Stock Report on CLX
About Clorox
(
Free Report)
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Read More
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
